FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amneal Pharmaceuticals of New York Divalproex Sodium Extended-release Tablets Recall

Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactu…

Amneal Pharmaceuticals of New York, LLC · Brookhaven, NY

Risk level
Class II
Reported by FDA
Apr 3, 2024
Recall ID
D-0426-2024
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals of New York recalled Divalproex Sodium Extended-release Tablets starting Dec 26, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0426-2024 on Apr 3, 2024. Reason: Failed dissolution specifications. Status: Terminated.

Why it was recalled

Failed dissolution specifications

Product description

Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10

Lot numbers, UPCs & expiration codes

Lot # AR210704, exp. date 04/2024 AR210706, exp. date 04/2024 AR210707, exp. date 04/2024 AR210708, exp. date 04/2024 AR210709, exp. date 04/2024

Where it was sold

Product was distributed nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0426-2024
Classification
Class II
Status
Terminated
Recall initiated
Dec 26, 2023
FDA report date
Apr 3, 2024
Quantity
21,452/100 count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals of New York, LLC

Original FDA data

Every field from FDA enforcement report D-0426-2024, exactly as published.

Show all FDA fields
City
Brookhaven
State
NY
Status
Terminated
Country
United States
Event ID
93976
Address
50 Horseblock Rd
Code information
Lot # AR210704, exp. date 04/2024 AR210706, exp. date 04/2024 AR210707, exp. date 04/2024 AR210708, exp. date 04/2024 AR210709, exp. date 04/2024
Postal code
11719-9509
Report date
Apr 3, 2024
Product type
Drugs
Recall number
D-0426-2024
Classification
Class II
Recalling firm
Amneal Pharmaceuticals of New York, LLC
Product quantity
21,452/100 count bottles
Termination date
Aug 16, 2024
Reason for recall
Failed dissolution specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10
Distribution pattern
Product was distributed nationwide.
Recall initiation date
Dec 26, 2023
Initial firm notification
Letter
Center classification date
Mar 27, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0426-2024, published Apr 3, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls